Company intelligence / Profile preview

MicroChannel Technologies

Huntington Beach, California, USA

Ownership: Private
Development stage: Other

Overview

MicroChannel Technologies (MCT) was a biotechnology company focused on developing proprietary microfluidic platforms for the isolation and analysis of rare cells, specifically circulating tumor cells (CTCs). The company's lead technology, the MCT-1 device, utilized microchannel-based separation to capture CTCs from blood samples, aiming to provide a non-invasive "liquid biopsy" for cancer diagnostics and monitoring. Based in Huntington Beach, California, MCT operated in the early 2000s and was a pioneer in the application of microfluidics for oncology diagnostics. The company is currently inactive and was dissolved in 2014.

Therapeutic areas: Oncology
Modalities: DeviceMicrofluidics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on MicroChannel Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroChannel Technologies.

Explore the full profile